NYLIM
EXEL icon

New York Life Investment Management’s Exelixis EXEL Stock Holding History

New York Life Investment Management’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
29,174
+8,832
+43% +$380K 0.01% 625
2025
Q4 		$892K Sell
20,342
-4,076
-17% -$169K 0.01% 635
2025
Q3 		$1.01M Sell
24,418
-1,451
-6% -$58.3K 0.01% 654
2025
Q2 		$1.14M Sell
25,869
-1,136
-4% -$45.4K 0.01% 621
2025
Q1 		$997K Buy
27,005
+338
+1% +$12K 0.01% 646
2024
Q4 		$888K Sell
26,667
-3,647
-12% -$118K 0.01% 683
2024
Q3 		$787K Sell
30,314
-3,550
-10% -$88.2K 0.01% 742
2024
Q2 		$761K Buy
33,864
+2,192
+7% +$48.6K 0.01% 741
2024
Q1 		$752K Sell
31,672
-3,891
-11% -$86.5K 0.01% 740
2023
Q4 		$853K Sell
35,563
-1,383
-4% -$30.1K 0.01% 695
2023
Q3 		$807K Buy
36,946
+17,425
+89% +$364K 0.01% 675
2023
Q2 		$373K Buy
+19,521
New +$376K ﹤0.01% 1099

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

New York Life Investment Management's EXEL Position: Q1 2026 in Review

New York Life Investment Management increased its Exelixis (EXEL) stake by 43% in Q1 2026, buying an estimated $380K and bringing the position to 29,174 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #625.

New York Life Investment Management first reported a position in EXEL in Q2 2023 and has held it in 12 quarters since. 696 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • New York Life Investment Management held 29,174 shares of Exelixis worth $1.25M as of Q1 2026.
  • New York Life Investment Management bought 8,832 Exelixis shares in Q1 2026, an estimated $380K.
  • Exelixis made up 0.01% of New York Life Investment Management's portfolio in Q1 2026, its #625 holding.
  • New York Life Investment Management first reported a position in Exelixis in Q2 2023 and has held it in 12 quarters since.
  • 696 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.